A study published in Diabetes Care has found that SGLT2 inhibitors are associated with fewer gout flares and reduced need for ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose ...

More than 5.8 million people are living with diabetes in the UK, and nine in 10 have type 2. This type occurs when the ...

A chronic, irreversible and life-long condition, Diabetes affects millions of people worldwide - for those who have this condition, it is either Type 1, or Type 2 diabetes. While both of them cause ...

People with type 2 diabetes usually have a higher risk of pancreatic cancer compared with people without type 2 diabetes. But that risk may depend on how long you’ve had type 2 diabetes. People who ...

More than 38 million Americans have diabetes and of them, up to 95% have type 2 diabetes, according to the Centers for Disease Control and Prevention (CDC). While the condition usually develops in ...

Children and adolescents with type 2 diabetes had an improvement in HbA1c at 26 weeks with a once-daily oral GLP-1, according ...

A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...